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Endogenous neurosteroids and neuroactive steroids have potent and widespread
actions on the brain via inhibitory GABAA receptors. In recombinant receptors and
genetic mouse models their actions depend on the α, β, and δ subunits of the
receptor, especially on those that form extrasynaptic GABAA receptors responsible for
non-synaptic (tonic) inhibition, but they also act on synaptically enriched γ2 subunit-
containing receptors and even on αβ binary receptors. Here we tested whether
behavioral sensitivity to the neuroactive steroid agonist 5β-pregnan-3α-ol-20-one is
altered in genetically engineered mouse models that have deficient GABAA receptor-
mediated synaptic inhibition in selected neuronal populations. Mouse lines with the
GABAA receptor γ2 subunit gene selectively deleted either in parvalbumin-containing
cells (including cerebellar Purkinje cells), cerebellar granule cells, or just in cerebellar
Purkinje cells were trained on the accelerated rotating rod and then tested for motor
impairment after cumulative intraperitoneal dosing of 5β-pregnan-3α-ol-20-one. Motor-
impairing effects of 5β-pregnan-3α-ol-20-one were strongly increased in all three
mouse models in which γ2 subunit-dependent synaptic GABAA responses in cerebellar
neurons were genetically abolished. Furthermore, rescue of postsynaptic GABAA
receptors in Purkinje cells normalized the effect of the steroid. Anxiolytic/explorative
effects of the steroid in elevated plus maze and light:dark exploration tests in mice
with Purkinje cell γ2 subunit inactivation were similar to those in control mice. The
results suggest that, when the deletion of γ2 subunit has removed synaptic GABAA
receptors from the specific cerebellar neuronal populations, the effects of neuroactive
steroids solely on extrasynaptic αβ or αβδ receptors lead to enhanced changes in the
cerebellum-generated behavior.
Keywords: extrasynaptic GABAA receptors, neurosteroids, cerebellum, motor performance, Purkinje cells
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INTRODUCTION
Endogenous neurosteroids and synthetic neuroactive steroids
are among the most potent and efficacious modulators of the
brain’s main ligand-gated inhibitory neurotransmitter receptor,
the γ-aminobutyric acid type A (GABAA) receptor, producing
wide-ranging effects on behavior, including motor relaxation
and impairment (Baulieu et al., 2001; Belelli et al., 2006).
The concentrations of neurosteroids in the brain are increased
in stress and by drugs, such as alcohol and antidepressants
(Barbaccia, 2004). Endogenous concentrations of neurosteroids
fluctuate during the ovarian cycle and in pregnancy, inducing
changes in GABAA receptor subtype populations, particularly
in those containing the δ subunits (Maguire et al., 2005;
Uusi-Oukari and Korpi, 2010; Wu et al., 2013; Mackenzie
and Maguire, 2014), which may result in impaired regulation
of mood in some patients (Backstrom et al., 2011, 2014).
Neurosteroid mechanisms have been implicated in acute liver
failure and hepatic encephalopathy (Ahboucha et al., 2012).
Furthermore, allopregnanolone, a metabolite of progesterone and
one of the main endogenous GABAergic neurosteroids, promotes
proliferation of neural progenitor cells in vitro via activation of
GABAA receptors and, after a single dose, enhances neurogenesis
in the hippocampal subgranular zone and in the dopaminergic
substantia nigra pars compacta of adult transgenic model mice
for Alzheimer’s disease (Wang et al., 2010; Zhang et al., 2015).
However, chronic treatment with allopregnanolone accelerates
Alzheimer’s disease in several types of mouse models (Bengtsson
et al., 2012, 2013). There appears to be a need to better understand
the mechanisms underlying neurosteroid sensitivity.
The mechanisms of neurosteroid sensitivity remain unclear.
Neurosteroid actions can be mediated by all subtypes of GABAA
receptors, with just α and β subunits giving full potency and
efficacy (Hosie et al., 2006). The type of the α subunit mediates
some of the variation noted in receptor properties, whereas
the type of the β subunit has less influence. In recombinant
receptors, inclusion of a γ2 subunit has little effect on binding
or efficacy compared to binary αβ receptors, but the inclusion of
the δ subunit strongly increases the GABA-potentiating effects
of neurosteroid agonists (Belelli et al., 2002; Wohlfarth et al.,
2002). Neurosteroids affect both synaptic (mainly γ2-GABAA
dependent) and extrasynaptic (mainly δ-GABAA dependent)
inhibition in brain slices, but, in line with the increased
efficacy of neurosteroids on δ subunit-containing receptors, their
behavioral and neurophysiological effects are strongly reduced
when extrasynaptic GABAergic inhibition has been attenuated,
e.g., in the GABAA receptor δ subunit knockout mice (Mihalek
et al., 1999; Spigelman et al., 2003; Stell et al., 2003). In the
case of extrasynaptic GABAA receptors containing the α4 and δ
subunits, these mechanisms involve protein kinase C activation,
and subsequent GABAA α4 subunit phosphorylation, increased
membrane insertion of these receptors, leading to enhanced tonic
conductance by prolonged exposure to neurosteroids (Abramian
et al., 2014). Thus, whereas neurosteroid agonists affect both
synaptic and extrasynaptic receptors, their behavioral effects
seem to primarily depend on extrasynaptic receptors. It is evident
that more information is needed on the effects of GABAA
receptor subunit composition on neurosteroid sensitivity at the
whole animal level.
In the present experiments, we genetically removed the γ2
subunit in discrete neuronal populations. We used male mice
to avoid estrus cycle-associated neurosteroid fluctuations. Using
a simple cerebellum-related behavioral task on rotating rods,
the mouse models enabled us to ascertain how the γ2 subunit
affects the sensitivity of the neuroactive steroid pregnanolone in
cerebellar circuitry. The cerebellum was very suitable for these
experiments, since the two main targets we used (Purkinje and
granule cells) are known to express the γ2 subunit and a limited
number of other subunits [Purkinje cells α1, β2/3 and γ2; granule
cells α1/6, β2/3, δ and γ2 (Wisden et al., 1996)]. The contributions
of extrasynaptic and synaptic GABAA receptors in mediating
pregnanolone effects were further validated by transgenic re-
introduction of the γ2 subunit into Purkinje cells (PC-γ2-swap
mice) (Wulff et al., 2007; Wisden et al., 2009).
MATERIALS AND METHODS
Animals
All mice used for experiments were male. Parvalbumin (Pv)-
neuron GABAA γ2 subunit knockout mice (Pv-1γ2) and
littermate control Pv-Cre mice were generated as described
(Wulff et al., 2009a), by crossing Pv-Cre mice with γ2I77 lox
mice (Fuchs et al., 2007; Wulff et al., 2007). Pv-1γ2 mice
were important for the study, since cerebellar Purkinje cells
and molecular layer interneurons are positive for parvalbumin
(Leppa et al., 2011), and thus lose synaptic inhibition. Cerebellar
granule cell (Gr) GABAA γ2 subunit knockout (Gr-1γ2)
homozygous (−/−), heterozygous (+/−) and wild-type (+/+)
littermate mice were generated by crossing α6-Cre mice
[B6.129P2-Gabra6tm2(cre)Wwis/Mmucd mouse mutant resource
stock MMRRC:015968-UCD (Aller et al., 2003)] with a mouse
line containing a γ2 gene flanked by lox P sites [Jax lab STOCK
No. 016830, Gabrg2tm2Lusc/J, also known as fγ2 mice (Schweizer
et al., 2003)]. Gr-1γ2 mice were used to study the effect of
γ2 subunit deficiency in only one major cerebellar neuron
population. Cerebellar Purkinje cell (PC) GABAA γ2 subunit
knockout mice (PC-1γ2) and littermate control γ2I77lox mice
were generated as described (Wulff et al., 2007), by crossing
γ2I77lox mice with L7-Cre mice (Barski et al., 2000; Wulff et al.,
2007). The γ2I77lox mice are available at JAX labs, stock STOCK
021197 Gabrg2tm1Wul/J, and have loxP sites surrounding exon 4
of the γ2 subunit gene (Wulff et al., 2007). The γ2I77lox mice
have the GABAA receptor γ2 subunit F77 residue point-mutated
to encode I77, causing an inability of the γ2 subunit-dependent
benzodiazepine binding site to mediate pharmacological effects
of the sedative-hypnotic zolpidem and the β-carboline convulsant
3-carbomethoxy-4-ethyl-6,7-dimethoxy-β-carboline (Cope et al.,
2005; Leppa et al., 2005) and to bind with high affinity the
universal benzodiazepine site ligand [3H]Ro 15-4513 (Leppa
et al., 2011; Linden et al., 2011) (see Figure 3C). In other
aspects the γ2I77 subunit-containing GABAA receptors function
normally (Cope et al., 2005). PC GABAA γ2 subunit swap
mice (PC-γ2-swap) were generated by expressing the wildtype
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γ2 subunit under the control of Purkinje-cell specific L7-
promoter to restore wildtype γ2 expression in PCs following
the specific inactivation of γ2 I77 subunit in these cells (in PC-
1γ2 mice). The PC-γ2-swap mice have been previously used
to selectively restore zolpidem sensitivity in Purkinje cells to
study how selective inhibition of PCs by zolpidem affects motor
performance (Wulff et al., 2007).
For all the conditional mouse crosses, all experiments were
performed on mice homozygous for the conditional γ2 allele and
hemizygous for the Cre transgenes; Cre-negative mice served as
the littermate controls. The mice were 4–10 months old when
used. Weights at the rotarod testing: Pv-1γ2 mice and their Pv-
Cre/γ2I77 controls 22± 3 (n= 7) and 25± 2 (8) g (mean± SD),
respectively; Gr-1γ2+/+, +/−, and −/− mice 32 ± 4 (5),
31 ± 2 (10), and 29 ± 1 (6) g, respectively; PC-1γ2, γ2I77lox
and PC-γ2-swap mice 25 ± 4 (5), 25 ± 6 (10) and 24 ± 2
(6) g, respectively. The animals were housed (1–5 per cage) in
transparent polypropylene Makrolon cages with standard rodent
pellets (Harlan Teklad Global Diet, Bicester, UK) and tap water
ad lib. Lights were on from 7 a.m. to 7 p.m.
All behavioral animal experiments were carried out with
the permissions (ESLH-2004-01605/Ym-23 and ESLH-2006-
09005/Ym-23) of the State Provincial Government of Southern
Finland, the governing body that oversaw animal ethics for the
University of Helsinki. All efforts were made to minimize the
number and suffering of animals. About 1 week after behavioral
tests, the animals were strongly sedated with CO2, decapitated,
and brains dissected out for further analyses.
Motor Tests
To investigate the motor coordination capabilities of each mouse
line rotarod tests were performed (Korpi et al., 1999). The
mice were trained during 7 days (4–6 trials per day) to stay
on a rotating rod (diameter 4 cm, Rotamex 4/8, Columbus
Instruments, Columbus, OH, USA) for 180 s, with the rotation
speed being linearly accelerated from 5 to 30 rpm. Due to the
impairment in motor performance of Pv-1γ2 mice, a lower
speed of 5 to 20 rpm was used in the training of these and their
littermate control mice. The latency to fall from the rod in each
trial was recorded and a daily average of 4–6 trials was calculated
for each animal.
To study the sensitivities of the mouse lines to neurosteroids
a synthetic neuroactive steroid 5β-pregnan-3α-ol-20-one
(pregnanolone, Sigma–Aldrich Chemical Company, St. Louis,
MO, USA) was used. Well-trained animals were injected
with vehicle or pregnanolone at 30 min intervals, 15 min
before each single-trial rotarod testing. Drug dosing was
cumulative, in order to reduce the number of tested animals
(vehicle+10+10+10 mg pregnanolone/kg, for the total dose
of 30 mg/kg). Cumulative dosing has been used successfully
in previous dose-response studies for other drugs (Cope
et al., 2004; Wulff et al., 2007). Pregnanolone was dissolved
overnight in cremophor (Cremophor EL, Sigma) and brought to
concentration with physiological saline (final concentration 30%
cremophor, which was used without pregnanolone as a vehicle
control). Pregnanolone and vehicle solutions were injected i.p. in
a volume of 10 ml/kg body weight.
Tests for Anxiolytic and Explorative
Activity
To compare the PC-mouse lines in the effects of pregnanolone
on the level of anxiety and explorative activity, we used a batch of
mice that was naïve to behavioral tests in elevated plus-maze test
and light:dark exploration test, as described in (Saarelainen et al.,
2008; Leppa et al., 2011), with 1 week washout between the tests.
The elevated plus-maze test was performed on the apparatus
made of gray plastic and elevated to 50 cm from the floor
level. It consisted of a central platform (5 cm × 5 cm), from
which two open arms (5 cm × 40 cm with a 0.7 cm ledge)
and two enclosed arms (5 cm × 40 cm × 20 cm) extended.
The mice were placed individually on the central platform facing
an open arm and allowed free exploration of the maze for
5 min with their behavior being recorded using a video tracking
system with a CCD video camera above the plus maze. This
was done 15 min after the injection of vehicle or pregnanolone
(10 mg/kg, i.p.), which was done in a balanced order. The
position and movements of the center of the animal’s surface area
were analyzed automatically using EthoVision software Color-
Pro 3.0 software (Noldus Information Technology, Wageningen,
Netherlands). The central area was extended to include the first
2 cm of each arm. An arm entry was recorded when the center
of the mouse entered the distal part of the arm. This corresponds
to the definition of an arm entry with all four legs on the arm.
During 5-min testing periods the time spent on the open arms,
the number of entries into the arms, and the total distance
traveled in the maze were recorded and analyzed by EthoVision.
The plus maze was carefully cleaned with water-moistened paper
towel and dried after each mouse, thus avoiding any aversive
smells to carry over to the next mouse. The mice were returned
to their home cage when all mice from the same cage were
tested.
The light:dark test (Saarelainen et al., 2008) was started by
placing a mouse in the lit compartment of two-compartment box
(47 cm× 29 cm× 35 cm) divided into one dark (16 cm× 29 cm)
and one lit (31 cm × 29 cm; about 450 lux) area with open
door (7 cm × 8 cm) between them. This was done 15 min after
the injection of vehicle or pregnanolone. In this test, we used
a slightly lower dose (7 mg/kg, i.p.) than in the elevated plus-
maze test to ensure that any sensitivity differences in anxiolytic
effects would be detectable. During 5-min testing periods the
time spent in the lit compartment, the number of crossings
between compartments and the distance traveled in the lit
compartment were recorded and analyzed by EthoVision. The
test-box was cleaned and dried after each mouse as was done
in the elevated plus-maze test, and the mice were returned
to their home cage when all mice from the same cage were
tested.
Ligand Autoradiography
Autoradiography of mouse brain horizontal 14-µm-thick
cryostat sections was performed as described (Korpi and
Luddens, 1997; Makela et al., 1997). For [3H]Ro 15-4513
autoradiography the sections were incubated at 4◦C for 60 min
with 15 nM [3H]Ro 15-4513 (Perkin-Elmer Life Sciences Inc.,
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Waltham, MA, USA). Non-specific binding was determined with
10 µM Ro 15-1788 (flumazenil, Tocris Bioscience, MS, USA).
For [35S]TBPS autoradiography the sections were incubated
with 6 nM [35S]-t-butylbicyclophosphorothionate ([35S]TBPS,
Perkin-Elmer) in the incubation buffer (50 mM Tris-HCl,
120 mM NaCl, pH 7.4) at room temperature for 90 min. Non-
specific binding was determined with 100 µM picrotoxinin
(Sigma). After the washing and drying, the sections were exposed
to Kodak Biomax MR film for 1–24 weeks with 3H (for
[3H]Ro 15-4513) or 14C (for [35S]TBPS) radioactivity standards
(Amersham Biosciences corp., Piscataway, NJ, USA). Binding
densities in the multiple locations of the granule cell and/or
molecular layers of the cerebellum were quantitated with MCID
M5-imaging software (Imaging Research Inc., St. Catherines
Ontario, ON, Canada) and converted to radioactivity values on
the basis of the simultaneously exposed standards. Non-specific
binding was subtracted from all values. Importantly, in [3H]Ro
15-4513 autoradiography, the radioligand concentration (15 nM)
was about three times higher than the dissociation constant Kd
of the binding (Sieghart, 1995). Thus, the images mainly reflected
the number of binding sites.
Ligand Binding to Recombinant
Receptors
Human embryonic kidney cells [HEK 293 cells; German
collection of microorganisms and cell cultures (DSMZ),
Braunschweig, Germany] were grown to <50% confluency on
15-cm tissue plates in 20 ml DMEM supplemented with 10%
heat-inactivated fetal calf serum, 5 mM glutamine as well as
penicillin and streptomycin. Transfection was carried out with
a Ca2+-phosphate precipitation method essentially as described
(Jordan et al., 1996). Briefly, plasmids were diluted in 1 ml/ plate
of 0.3125 M CaCl2 in H2O. One ml/ plate of 2x HBS (274 mM
NaCl; 1.5 mM Na2HPO4; 54.6 mM HEPES/NaOH; pH 7.0)
was added to the DNA and incubated for 90 s. Two ml of the
mixture were pipetted into 15-cm plates that were incubated for
18–24 h before the transfection medium was replaced by fresh
medium. Double and triple combinations of rat GABAA receptor
cDNAs in eukaryotic expression vectors (Pritchett and Seeburg,
1990) of the α1, β3, γ2S, and δ subunits were employed. Final
concentrations (µg vector DNA per 15 cm tissue culture plate)
were: α1, 2.5; β3, 0.5; γ2S, 0.375, and δ, 2.5.
Cell membranes were prepared as described (Korpi and
Luddens, 1997). Resuspended crude cell membranes (50–200 µg
protein per tube) were incubated in a final volume of 0.5 ml
of 50 mM Tris/citrate buffer supplemented with 0.2 M NaCl,
pH 7.3, with 3 nM [3H]EBOB ([3H]ethynylbicycloorthobenzoate,
NEN) with or without pregnanolone in the presence or absence
of GABA. Pregnanolone was made up in DMSO at a stock of
10 mM in DMSO. GABA was diluted from a 100 mM solution in
H2O. Binding assay procedure was performed as described earlier
(Korpi and Luddens, 1997).
Statistical Analyses
Statistical tests were performed with SPSS Software (SPSS 12.0.1,
SPSS Inc., Chicago, IL, USA) or GraphPad Prism software
FIGURE 1 | Neurosteroid sensitivity of Pv-1γ2 mice with targeted
inactivation of GABAA receptor γ2 subunit gene in
parvalbumin-expressing neurons. (A) Learning the rotarod performance.
The rotarod was accelerated from 5 to 20 rpm during 180 s. Data for γ2I77lox
control (n = 8) and Pv-1γ2 (n = 7) mice are presented as daily means of 6
trials ± SEM. #P < 0.05 for the significance of the difference between the
mouse lines on training days 1 and 2 (repeated measures ANOVA and
Newman–Keuls post hoc tests). (B) Effects of pregnanolone on motor
performance. Pregnanolone was administered in cumulative doses
(10+10+10 mg/kg i.p., total 30 mg/kg) to the same animals and the
performance tested as in panel (A). One-way ANOVA and Newman–Keuls
post hoc tests: ##P < 0.01, ###P < 0.001 for the significance of the difference
between the mouse lines, ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 for the
significance of the difference from vehicle injection within the Pv-1γ2 line.
Data are presented as means ± SEM.
(Prism 6.0, GraphPad Software Inc., San Diego, California,
USA). Treatment groups and mouse lines were compared with
either repeated measures ANOVA, one-way ANOVA or two-way
ANOVA followed by Newman–Keuls post hoc test or Dunnett’s
test. In all statistical tests the level of significance was set at
P < 0.05.
RESULTS
A mouse line [Pv-1γ2, (Wulff et al., 2009a)] with inactivated
synaptic GABAA receptor-mediated inhibition of Pv-expressing
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neurons exhibited a high sensitivity to the exogenous neuroactive
steroid 5β-pregnan-3α-ol-20-one (pregnanolone; Figure 1).
Naive Pv-1γ2 mice exhibited ataxia, but they could learn to
stay on a rotating rod that accelerated from 5 to 20 rpms
(Figure 1A). However, when these mice were challenged by
cumulative dosing of pregnanolone they quickly fell down from
the rod, while the control littermates were only slightly affected
(Figure 1B, drug treatment× genotype interaction F3,53 = 5.33,
P < 0.01). Electrophysiology of the Pv-expressing hippocampal
interneurons in the genetically engineered mice indicated
abolition of synaptic GABAA receptor-mediated inhibitory
postsynaptic currents (IPSCs) (Wulff et al., 2009a). Pv-expression
is widespread in the brain, including the cerebellar PCs (Meyer
et al., 2002; Leppa et al., 2011; Kaiser et al., 2015). Thus, it seemed
possible that neurosteroids can induce strong neuronal effects
especially in the absence of their target receptors from a set of
synapses.
Since Pv-expressing neurons exist at a low and diffuse
level in most areas of the central nervous system, including
motor neurons of the brain stem and spinal cord, and because
they have abundant connections between each other and to
principal neurons throughout the brain, interpretation of the
effect of global Pv-cell-specific elimination of synaptic inhibition
is complicated. Thus, we next wanted to use a mouse model
with a more restricted ablation of synaptic inhibition. We
produced cerebellar granule cell-selective GABAA receptor γ2
subunit knockout mice (Gr-1γ2) by cross-breeding α6-Cre
(Aller et al., 2003) and floxed γ2 mice (Schweizer et al.,
2003). Autoradiography of cerebellar sections showed that in
the granule cell layer, the Gr-1γ2 knockouts lack the γ2
FIGURE 2 | Neurosteroid sensitivity of Gr-1γ2 mice with targeted inactivation of GABAA receptor γ2 subunit gene in the cerebellar granule cells.
(A) Ligand binding sites in horizontal brain sections from Gr-1γ2 mice with the wildtype γ2 subunit background. [3H]Ro 15-4513 labels the γ2 subunit-dependent
flumazenil-sensitive benzodiazepine sites, which are deficient in the cerebellar granule cell layer of the genetically engineered mice, but not in the molecular layer (as
shown in the bar graph). [35S]TBPS labels the picrotoxin-sensitive ionophore sites of the GABAA receptor, and this labeling is intact in the cerebellum of the
genetically engineered mice, suggesting normal amounts of α and β subunit expression. (B) Rotarod learning. The rotarod was accelerated from 5 to 30 rpm during
180 s. Data for wild-type +/+ (n = 5), heterozygous +/− (n = 10) and Gr-1γ2 knockout −/− (n = 6) mice are presented as daily means of 6 trials ± SEM. There
were no significant differences between mouse lines. (C) Effects of pregnanolone on rotarod performance. Pregnanolone was administered in cumulative doses
(10+10+10 mg/kg i.p., total 30 mg/kg) to the same animals, and the performance tested, as in panel (B). ANOVA followed by Newman–Keuls post hoc tests:
¤P < 0.05 for the significance of the difference of +/+ and +/− mice from the −/− mice. ∗P < 0.05, ∗∗∗P < 0.001 for the significance of the difference compared to
vehicle within lines. Data are presented as means ± SEM.
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subunit-dependent high-affinity labeling of the benzodiazepine
binding sites, but contain normal labeling of integral ionophore
sites of GABAA receptors (Figure 2A). This is consistent
with the loss of γ2 subunit-containing receptors at synapses
between GABAergic Golgi interneurons and granule cells. In
spite of these deficits in synaptic receptors, the Gr-1γ2 mice
learnt normally to run on a rotarod and did not show
obvious motor deficits (Figure 2B). Interestingly, these mice
showed a significant increase in pregnanolone sensitivity as
compared to littermate controls and heterozygous knockouts
(Figure 2C; drug treatment × genotype interaction F6,72 = 2.87,
P < 0.05).
Our third mouse model focused on manipulating inhibitory
synaptic input to cerebellar Purkinje cells. We performed motor
tests in male PC-1γ2 mice (Wulff et al., 2007). These mice lack
the spontaneous IPSCs of Purkinje neurons (Wulff et al., 2007),
but they exhibited only a minor transient motor impairment
during the 1st day of rotarod training. The motor-impairing effect
of pregnanolone on rotarod performance was clearly enhanced
in PC-1γ2 mice as compared to littermates (Figures 3A,B;
FIGURE 3 | Neurosteroid sensitivity of PC-1γ2 mice with targeted inactivation of GABAA receptor γ2 subunit gene in the cerebellar Purkinje neurons.
(A) Effects of pregnanolone on motor performance. Pregnanolone was administered in cumulative doses (10+10+10 mg/kg i.p., total 30 mg/kg) to the control
γ2I77lox (n = 5) and PC-1γ2 (n = 5) mice, and the performance tested on accelerating rotarod (from 5 to 30 rpm) during 180 s. ANOVA followed by Newman–Keuls
post hoc tests: ##P < 0.01 for the significance of the difference between the mouse lines, ∗P < 0.05 for the significance of the difference compared to vehicle within
the PC-1γ2 line. Data are presented as means ± SEM. (B) Effects of wildtype γ2 subunit rescue to the Purkinje neurons in PC-γ2-swap mice on pregnanolone
sensitivity. Drug administration and testing of γ2I77lox (n = 10), PC-1γ2 (n = 5) and PC-γ2-swap (n = 6) mice were carried out as in panel (A). ANOVA followed by
Newman–Keuls post hoc tests: #P < 0.05, ##P < 0.01 for the significance of the difference between PC-1γ2 and γ2I77lox mice. ¤P < 0.05 for the significance of
the difference between PC-1γ2 and PC-γ2-swap mouse lines. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001 for the significance of the difference compared to vehicle
injection within the mouse lines. Data are presented as means ± SEM. (C) Representative images of γ2 subunit-dependent [3H]Ro 15-4513 binding in normal
wildtype C57BL/6J, γ2I77lox, PC-1γ2 and PC-γ2-swap mouse horizontal brain sections, demonstrating a clear rescue of molecular layer binding in PC-γ2-swap
mice. Please, note the very low binding in the forebrain regions in the brains with γ2I77lox background as compared to the wildtype brain. Representative cerebellar
images of GABAA receptor ionophore binding sites labeled with [35S]TBPS show unchanged binding in genetically engineered mice.
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drug treatment × genotype interaction, F6,69 = 2.96, P = 0.05).
Importantly, the re-introduction of wildtype γ2 subunits to
PCs, as evidenced by autoradiographic (Figure 3C) and
electrophysiological experiments (Wulff et al., 2007), fully
abolished the increased pregnanolone sensitivity (Figure 3B;
P > 0.05 for the difference between PC-γ2-swap and γ2I77lox
lines). These results finally implicate PCs as targets of
pregnanolone in the cerebellar cortex resulting in impaired motor
coordination.
To test whether PC-1γ2 mice show enhanced sensitivity
in other than motor coordination tests, doses of pregnanolone
that are not strongly motor impairing (7 and 10 mg/kg)
were tested for possible anxiolytic/exploration-increasing effects
in the elevated plus maze and light:dark exploration tests,
but the results were essentially similar in γ2I77lox and PC-
1γ2 mice (Figure 4), thus showing no baseline differences in
any measures, nor any significant mouse line or interaction
effects in the ANOVA. Pregnanolone treatment induced an
anxiolytic-like effect that was similar in both mouse lines. It
significantly increased the time on the open arms (F1,29 = 11.8,
P = 0.002) and the proportion of open arm entries (F1,29 = 12.2,
P = 0.0015) and reduced the distance moved (F1,29 = 7.6, P
= 0.01) in the plus maze test, and it tended to increase
the time in the lit compartment (F1,31 = 3.44, P = 0.07),
increased number of crossings between the compartments
(F1,31 = 7.07, P = 0.012) and increased distance traveled
in the lit compartment (F1,31 = 7.34, P = 0.010) in
the light:dark test. Furthermore, PC-1γ2 mice showed no
reduction in locomotor activity in these tests as compared to
controls.
Purkinje cells express especially the α1 subunit-containing
GABAA receptors (Wisden et al., 1996). Therefore, we used
recombinant GABAA receptors to assess whether different α1
subunit-containing receptor subtypes are affected by the presence
of pregnanolone. In the absence of GABA, among α1β3, α1β3γ2,
and α1β3δ receptors only the δ subunit-containing receptor
α1β3δ responded to increasing concentrations of pregnanolone
with increased binding of [3H]EBOB (Figure 5). At 1 µM
GABA, pregnanolone reduced [3H]EBOB binding to α1β3 and
α1β3γ2 receptors (Figure 5), but had no effects on α1β3δ. At the
highest GABA concentration tested (10 µM), high nanomolar
pregnanolone reduced the binding to α1β3δ receptors but had
no more effects on the already low binding to α1β3 and α1β3γ2
receptors. These data suggest that also in a biochemical assay of
recombinant GABAA receptor function, the δ subunit-containing
receptors respond strongly to the presence of pregnanolone.
More importantly, the α1β3 receptors that do not have the
address to go to synapses are as strongly affected as α1β3γ2
receptors by pregnanolone.
DISCUSSION
Neurosteroids are potent modulators of brain GABAA receptors
and their significance to various behavioral states is under
active investigation. The level of endogenous neurosteroids is
thought to influence neuronal excitability, e.g., in catamenial
epilepsy, premenstrual syndrome and migraine as well as
depression (van Broekhoven and Verkes, 2003; Wu et al., 2013;
Backstrom et al., 2014). Neurosteroid mechanisms seem to
be important also in liver failure and hepatic encephalopathy
(Ahboucha et al., 2012) and in Alzheimer’s disease models
(Wang et al., 2010; Bengtsson et al., 2012, 2013; Zhang et al.,
2015). Using several GABAA receptor genetically engineered
mouse models we show here that the neuroactive steroid agonist
pregnanolone can strongly modulate learned motor performance
when the balance of non-synaptic (extrasynaptic) and synaptic
GABAA receptors was altered in a set of neuronal populations
FIGURE 4 | Effects of pregnanolone on PC-1γ2 mice with targeted inactivation of GABAA receptor γ2 subunit gene in the cerebellar Purkinje neurons
in tests for anxiety and exploration. The γ2I77lox and PC-1γ2 mice were treated with vehicle or pregnanolone (at doses indicated below the bars, in mg/kg i.p.)
and 15 min later tested in the elevated plus maze (A) and light:dark exploration (B) tests. The results (means ± SEM, n = 7–9 per group) show no differences
between mouse lines (two-way ANOVA, P > 0.1), but significant effects by the treatment in both tests for all measures (P < 0.013), except for the % time in the lit
area (P = 0.07).
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FIGURE 5 | Effects of pregnanolone on GABAA receptor subtypes in
the presence and absence of GABA. GABAA receptors of the given
subunit combinations were transiently expressed in HEK 293 cells and
incubated with 3 nM [3H]EBOB in the presence and absence of GABA and
increasing concentrations of pregnanolone, as indicated. Data are presented
as the means ± SEM, n = 3–5. All data were normalized to the [3H]EBOB
binding with setting 0-µM GABA + 0-µM pregnanolone to 100%.
with inactivated γ2 subunits. Previous findings on α4 and
δ subunit-containing receptors in hippocampal areas indicate
that neurosteroid agonists powerfully facilitate tonic inhibition
mediated by GABAA receptors (Carver et al., 2014). These results,
together with the reduced sensitivity of neurosteroids in GABAA
receptor δ knockout mice (Mihalek et al., 1999; Stell et al.,
2003), strongly indicate that the extrasynaptic GABAA receptors
are the preferential targets of neurosteroids. Importantly, in
the present study these preferential effects could be detected
in mice with impaired synaptic inhibition only in a single
population of neurons after inactivation of the γ2 subunit that
is essential for synaptic targeting of GABAA receptors (Crestani
et al., 1999), without any general enhancement of δ subunit-
containing GABAA receptors. It should anyway be kept in mind
that compensatory changes may take place after inactivation
of γ2 subunits, although the δ subunit is not known to be
expressed in the cerebellar PCs (Wisden et al., 1996) and global γ2
inactivation cannot be efficiently compensated in mice (Gunther
et al., 1995).
The modulation of binding of the GABAA receptor ionophore
ligand [3H]EBOB was different in the δ subunit-containing
receptors than in binary αβ or γ2 subunit-containing
receptors (Figure 5), again indicating a possibility that δ
subunit-containing GABAA receptors have features that make
neurosteroid effects in them more potent or efficient. Further
study is needed to understand the molecular mechanisms how
the general neurosteroid binding sites on α subunits (Hosie et al.,
2009) are transducing the signal to the ionophore structure in the
δ subunit-containing receptors differently from δ subunit-absent
receptors.
The alteration of balance between synaptic and extrasynaptic
inhibition might be also operative in the regulation of other
neuronal pathways that mediate more subtle behaviors such as
emotions and irritability, that are known to be associated with
altered endogenous neurosteroid metabolism and GABAergic
inhibition (Backstrom et al., 2003). In the present study the
anxiolytic and exploration-related effects of pregnanolone were
not affected by the γ2 inactivation in the cerebellar PCs
(Figure 4). The tests should be extended in further studies
by using more appropriate neuronal populations for emotional
regulation, e.g., in the forebrain.
Learned motor performance depends on cerebellar circuitry.
In a recent study, the conditioned eyeblink reflex was pinpointed
to deep cerebellar nuclei, particularly the anterior interpositus
nuclei, which receive input from cerebellar cortical PCs (Ito,
1984; Heiney et al., 2014). PCs have multiple roles in movement
precision, including predictive activity and instructive signaling
downstream to the deep cerebellar nuclei. Optogenetic activation
of PCs-inhibiting interneurons in the molecular layer transiently
decreases the constitutive inhibitory output of PCs to the
deep cerebellar nuclei and consequently produces precisely
timed movement activation in awake mice (Heiney et al.,
2014). Our present findings of enhanced motor impairment
by pregnanolone acting on non-synaptic GABAA receptors in
various cerebellar cortical neuron populations likely resulted
from non-timed prolonged disinhibition of the deep cerebellar
nuclei.
In Pv-1γ2 mice the predicted absence of synaptic inhibition
with maintained extrasynaptic inhibition in widespread brain
regions resulted in a pronounced increase in pregnanolone
sensitivity in the rotarod test. Importantly, cerebellar molecular
layer interneurons, such as stellate and basket cells are Pv-
positive, as are the PCs as well (Meyer et al., 2002; Kaiser
et al., 2015), and the inhibitory feed-forward control the
molecular layer interneurons exert on PCs via synaptic GABAA
receptors is perforce altered in Pv-1γ2 mice (Wulff et al.,
2009b). When pregnanolone is administered, it affects the
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cerebellar function in these knockout mice more strongly than
in wild-type mice. Considering that the synaptic inhibitory
influence of molecular layer interneurons on PCs is already
lacking, the effect of pregnanolone on remaining extrasynaptic
receptors in both PCs and stellate/basket cells produces a network
inhibitory effect that impairs the learned motor behavior of
Pv-1γ2 mice.
Pregnanolone produced a robustly increased effect on
learned motor performance also in Gr-1γ2 mice. Despite
the missing synaptic inhibition from Golgi interneurons to
granule cells (correlating with the absence of α1/6βγ2 subunit-
dependent [3H]Ro 15-4513 binding, Figure 2A), these mice
learned motor tasks as well as wild-type mice, suggesting
compensations. Normally cerebellar granule cells have an
excitatory effect on Purkinje cells via parallel fiber axons.
When Gr-1γ2 mice are administered pregnanolone, this
excitation is possibly reduced to a greater extent and/or
the phasic changes in PC firing are blunted compared to
wild-type mice due to the prevalence of only extrasynaptic
receptors in the granule cells. The resulting decrease in
timed PC activity is a likely explanation for the increased
impairing effect of pregnanolone on motor performance. This
cerebellar granule-cell specific mouse model revealed that
ablation of phasic inhibition only in a single population of
cerebellar neurons, although in the most abundant one of
the brain, is enough to bring about enhanced neurosteroid
sensitivity.
Purkinje cell-1γ2 mice were previously found to have
disrupted inhibitory and excitatory input timing from PCs
and mossy fiber collaterals (Wulff et al., 2009b). The lack
of the GABAA γ2 subunit disrupts the coordination of
PC activity through molecular layer interneurons. In the
present study powerfully prolonged tonic inhibition of PC
activity by pregnanolone acting on extrasynaptic GABAA
receptors would disrupt the learning and performance of
motor tasks more in PC-1γ2 than in wild-type mice due
to the sole availability of presumably α1β2 extrasynaptic
receptors. Compensatory mechanisms, such as up-regulation
of δ subunit expression, cannot be excluded, though. In
PC-γ2-swap mice the situation was normalized due to the
restoration of synaptic GABAergic inhibition in the molecular
layer. As compared to the normal γ2F77 wild-type mice, the
rescue of γ2-dependent benzodiazepine site binding in PC-
γ2-swap was only 23% (Figure 3C), but this comparison
may underestimate the rescue, since it does not take into
account the binding to molecular layer interneurons missing
at the γ2I77 background. Anyway, this mouse model with
the rescue experiment pinpointed that the presence of γ2
subunits and associated synaptic inhibition strongly blunted the
effect of pregnanolone on motor performance, underscoring
the importance of phasic, directly neurotransmission-linked
inhibition. Each PC receives a robust, convergent inhibition
from about seven GABAergic, gap-junctionally connected
interneurons in the molecular layer (Hausser and Clark,
1997; Park et al., 2012; Kim et al., 2014). The abolition
of this phasic function should at least affect the timing of
inhibition and thereby the regulation of firing of different
PCs and at the end the motor performance. In the absence
of γ2 subunits, pregnanolone presumably induced prolonged
inhibition of PC firing via extrasynaptic receptors. Alternative
mechanisms could involve cerebellar glutamatergic N-methyl-
D-aspartate receptors that might undergo adaptive changes in
neurons with deficient synaptic inhibition [synaptic scaling;
cf. (Moykkynen et al., 2007)], especially as some neurosteroids
blunt cerebellar responses to glutamate via potentiating
GABAA receptor functions or by blocking glutamate receptors
(Cauli et al., 2011; Bali and Jaggi, 2014; Vyklicky et al.,
2015).
CONCLUSION
Taken as a whole, these results from four different genetically
engineered mouse lines with disruptions in the synaptic
connections of the cerebellar network point to a delicate balance
of inhibitory and excitatory input toward PCs. A possible
interpretation of our results is that reduced inhibition from
PCs toward the deep cerebellar nuclei, resulting from either
decreased excitation (Gr-1γ2 mice) or increased sustained
inhibition of PCs (Pv-1γ2 and PC-1γ2 mice), caused the
increased effect of pregnanolone on the rotarod test performance.
These mouse models may form the basis for studies on
molecular mechanisms of neurosteroid actions and for detailed
understanding of how the cerebellar cortex regulates motor
performance.
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